Letter by Romanens and Miserez regarding article, "Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial"

Circulation. 2006 Sep 19;114(12):e506; author reply e507-8. doi: 10.1161/CIRCULATIONAHA.106.617688.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticholesteremic Agents / therapeutic use*
  • Atorvastatin
  • Calcinosis / blood
  • Calcinosis / drug therapy
  • Calcinosis / physiopathology
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / drug therapy*
  • Coronary Artery Disease / physiopathology
  • Dose-Response Relationship, Drug
  • Heptanoic Acids / therapeutic use*
  • Humans
  • Pyrroles / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Reproducibility of Results
  • Sample Size

Substances

  • Anticholesteremic Agents
  • Heptanoic Acids
  • Pyrroles
  • Atorvastatin